Chronic dyspnea, defined as persistent or progressive shortness of breath, is a common symptom in patients with chronic respiratory, cardiovascular, or neuromuscular conditions and significantly impacts quality of life. Chronic dyspnea management involves a comprehensive approach aimed at relieving symptoms, improving functional capacity, and enhancing daily living activities. Assessment begins with identifying underlying causes, evaluating pulmonary and cardiac function, and reviewing comorbidities that may exacerbate breathlessness. Interventions may include pharmacological therapies, such as bronchodilators, anti-inflammatory agents, or cardiovascular medications, alongside non-pharmacological strategies like pulmonary rehabilitation, breathing exercises, and physical conditioning to strengthen respiratory muscles. Chronic dyspnea management also emphasizes patient education on energy conservation, pacing techniques, and strategies to recognize early signs of exacerbation. Supplemental oxygen and ventilatory support may be indicated for patients with severe or refractory symptoms, while multidisciplinary collaboration among pulmonologists, physiotherapists, nutritionists, and mental health professionals ensures a holistic approach. Recent research highlights the value of integrative therapies, including mindfulness, relaxation techniques, and structured exercise programs, in reducing anxiety and improving symptom perception. Continuous monitoring and adjustment of treatment plans are critical for achieving sustained relief and preventing hospitalizations. By combining targeted medical interventions, lifestyle modifications, and patient-centered education, chronic dyspnea management enhances respiratory efficiency, quality of life, and overall functional independence in individuals affected by long-term respiratory compromise.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation